QuidelOrtho Corp. (QDEL)
15.24
-1.33
(-8.03%)
USD |
NASDAQ |
Mar 20, 16:00
15.25
+0.01
(+0.07%)
After-Hours: 20:00
QuidelOrtho Research and Development Expense (Quarterly) : 45.80M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AtriCure, Inc. | 22.74M |
| Boston Scientific Corp. | 569.00M |
| Integer Holdings Corp. | 10.11M |
| Tandem Diabetes Care, Inc. | 46.07M |
| Establishment Labs Holdings, Inc. | 5.434M |